Search

everythinglearnresearchcommunity

for

Search:↓

The AA-IGA scale reliably measures treatment success in alopecia areata by considering both clinician and patient views.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Wharton's jelly-derived stem cells were safely used to treat four alopecia patients, resulting in hair regrowth in all of them.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

Janus kinase inhibitors reduce inflammation markers in severe alopecia areata patients.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Unorthodox dosing of tofacitinib and baricitinib is safe but less effective than standard dosing for treating alopecia areata in kids.

New medications could improve treatment for severe alopecia areata in Australia.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Baricitinib is effective and safe for long-term treatment of severe alopecia areata.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

Vitamin D analogues can significantly help hair regrowth in Alopecia Areata patients.

rwSALT provides precise hair regrowth measurement from scalp photos.

A 12-year-old boy with twenty nail dystrophy, a condition affecting all nails, was treated conservatively due to its self-limiting nature and good prognosis.

A child with rough nails also had hair loss and allergies.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

A new tool simplifies alopecia areata severity scoring but needs validation.

Sandalore®, a synthetic scent, improved hair loss and satisfaction in women with telogen effluvium.

Alopecia Areata affects 2% globally, with treatments like essential oils, garlic, and JAK inhibitors showing promise, but more research is needed.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.